Barbara Pucci

Barbara Pucci

Auto-generated profile, based on publicly available information

Barbara Pucci

Department of Medicine, Surgery and Neurosciences University of Siena Siena Italy

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2021 in Acta Neurologica Scandinavica
Verified
Journal Article
Closed access
PDF file
AGAnna Rita Giovagnoli
Anna Rita Giovagnoli
APAnnalisa Parente
Annalisa Parente
RCRoberta Ciuffini
Roberta Ciuffini
GTGiulia Maria Tallarita
Giulia Maria Tallarita
KTKatherine Turner
Katherine Turner
TAthe Study Group on Cognitive Neurology, Neuropsychology – Adult Section of the Italian League AgainstEpilepsy
the Study Group on Cognitive Neurology, Neuropsychology – Adult Section of the Italian League AgainstEpilepsy

12 August 2023 in Acta Neurologica Scandinavica
Verified
Journal Article
Open access
PDF file
GTGiulia Maria Tallarita
Giulia Maria Tallarita
RCRoberta Ciuffini
Roberta Ciuffini
KTKatherine Turner
Katherine Turner
BPBarbara Pucci
Barbara Pucci
APAnnalisa Parente
Annalisa Parente
AGAnna Rita Giovagnoli
Anna Rita Giovagnoli
Objectives. Social cognition (SC) is a multifaceted concept involving mental processes to understand, store, and apply information regarding social relationships. Brain lesions in key areas can impair critical components of SC, but seizures and epileptiform discharges could also be associated with deficits in SC. To verify this hypothesis, this study evaluated SC in persons with generalized or focal epilepsy without detectable brain lesion. Materials and Methods. Forty-eight adult persons with idiopathic generalized epilepsy (IGE) or temporal lobe epilepsy without brain lesion (cryptoTLE) and 24 healthy controls were evaluated by means of the Faux Pas Test (FPT), Social Situation Test (SST), Moral/Conventional Distinction Test (MCDT), and Empathy Questionnaire (EQ) which assess theory of mind (ToM), recognition of social behaviors and moral and conventional rules, and empathy. Clinical work-up included information on age at seizure onset, epilepsy duration, seizure symptoms and frequency, demographic characteristics, and the presence of comorbidities. Results. Compared to controls, persons with IGE or cryptoTLE were impaired in the understanding of existent faux pas on the FPT. On the SST, persons with cryptoTLE also showed significant deficits, whereas the IGE persons only were less accurate in recognizing normative behaviors. In cryptoTLE persons, the capacity to recognize cognitive and affective mental states correlated with seizure frequency and age, whereas, in IGE persons, the SST and MCDT scores correlated with schooling and age, respectively. Conclusions. CryptoTLE can cause extensive deficits in ToM and recognition of social situations, whereas IGE is only associated with deficits in fewer domains. Dysfunction of temporolimbic areas could be related to seizure frequency and associated with more severe SC impairment in cryptoTLE. Older age and poor education may be associated with SC deficits in focal or generalized epilepsy.

11 November 2025 in European Journal of Neurology
Verified
Journal Article
Open access
DLDiego Lopergolo
Diego Lopergolo
DGDaniele Gasparini
Daniele Gasparini
SBSilvia Bianchi
Silvia Bianchi
BPBarbara Pucci
Barbara Pucci
DTDomenico Tripodi
Domenico Tripodi
AMAndrea Mignarri
Andrea Mignarri
Introduction: Several studies have previously demonstrated an increased risk of dementia and brain amyloid deposition in individuals with heterozygous NPC1 mutations. Moreover, in a recent study, we identified the first family with autosomal dominant late‐onset Alzheimer's disease (AD) caused by a heterozygous NPC1 mutation. Unfortunately, there are currently no effective treatments available for this condition. Miglustat, which impacts the metabolism of oxysterols, has been shown to exert an anti‐amyloidogenic effect in a human cellular model of AD. Methods: In our exploratory uncontrolled study, three patients from the previously published family were orally treated with miglustat for 12 months. They underwent monthly clinical evaluations and routine blood tests. Additionally, neuropsychological evaluations, brain amyloid‐PET imaging, and biochemical analyses on plasma and CSF were performed. Results: All three patients achieved clinical stability, showed a sustained reduction in serum oxysterol levels, and experienced a marked decrease in brain amyloid burden. Discussion: Based on our preliminary observations and hypothesis‐generating findings, along with the growing evidence suggesting AD as a lipid disorder, miglustat should be further tested in a larger cohort of heterozygous NPC1 mutated patients and probably evaluated as a potential disease‐modifying treatment for AD.

10 June 2021 in Journal of Perinatal Medicine
Verified
Journal Article
Closed access
SLSara Lazzarin
Sara Lazzarin
SOSara Ornaghi
Sara Ornaghi
LDLuca Maria Pietro D’aNdrea
Luca Maria Pietro D’aNdrea
BPBarbara Pucci
Barbara Pucci
PVPatrizia Vergani
Patrizia Vergani
Article Comment on: “amniotic fluid embolism – implementation of international diagnosis criteria and subsequent pregnancy recurrence risk” was published on September 9, 2021 in the journal Journal of Perinatal Medicine (volume 0, issue 0).